Global Capital Service Group, Ltd Life Sciences
Maria Luisa R. Candelore, MSc, has joined GCaps as Director for all projects in the Life Sciences sector.
Mari was most recently Director in the External Scientific Partnerships group supporting strategic interests of JDRF, a non-profit 501(c)(3) formerly known as the Juvenile Diabetes Research Foundation. In her role, Mari worked at the research-business interface providing support to the JDRF Research Team in the identification, analysis, formation and project management of strategic research alliance and partnership collaborations with academics and the healthcare industry to further the mission of the JDRF in T1D. Among her duties was close work with the Research Team to evaluate industry proposals for research funding, to help create the business case, and to lead in agreement negotiations. Specifically, she supported the evaluation of devices for an artificial pancreas project, microbiome, beta cell regeneration, and repurposing of drugs with potential to impact the lives of people with diabetes.
Mari Candelore came to JDRF from Merck Research Laboratories' External Scientific Affairs Department, where she engaged in licensing, contract negotiation and alliance management activities. She supported biology and technology deals from their early stages, clinical development through to commercialization (in both U.S. and developing markets). Prior to her licensing, Mari was a "bench scientist" at Merck, working in several therapeutic areas: o Microbiology/Molecular Biologyo Growth Factor Researcho Molecular Pharmacologyo Obesityo Immunologyand lastly, in Diabetes, under Dr. Bei Zhang to develop novel inhibitors of gluconeogenesis. Mari has authored or co-authored more than sixty peer-reviewed publications and presented her work at major international conferences. She is a graduate of Vassar College and received her Master's Degree in Biology from New York University.
Mari Candelore came to JDRF from Merck Research Laboratories' External Scientific Affairs Department, where she engaged in licensing, contract negotiation and alliance management activities. She supported biology and technology deals from their early stages, clinical development through to commercialization (in both U.S. and developing markets). Prior to her licensing, Mari was a "bench scientist" at Merck, working in several therapeutic areas: o Microbiology/Molecular Biologyo Growth Factor Researcho Molecular Pharmacologyo Obesityo Immunologyand lastly, in Diabetes, under Dr. Bei Zhang to develop novel inhibitors of gluconeogenesis. Mari has authored or co-authored more than sixty peer-reviewed publications and presented her work at major international conferences. She is a graduate of Vassar College and received her Master's Degree in Biology from New York University.